Triple-negative breast cancer is the most aggressive form of the disease, and it often spreads to the brain. Treatment options remain limited, and outcomes for patients are often poor.
A Review in @TheLancetOncol draws together the latest evidence to provide a roadmap for unmet clinical needs: spkl.io/60197ziZf